Page 124 - 《中国药房》2022年19期
P. 124

·“一切为了人民健康——我们这十年”专栏·


              编者按:为了迎接党的二十大胜利召开,生动展现党的十八大以来以习近平同志为核心的党中央把维护人民健康摆在更加突
          出的位置、全面推进健康中国建设的光辉历程和辉煌成就,我刊特从2022年8月起开设“一切为了人民健康——我们这十年”专
          栏,从我刊实际出发,陆续推出一系列总结我国药学领域进展的文章,从而助力健康中国建设。本期专栏文章《药品集中采购背景
          下慢性病患者药品福利获得感及影响因素研究》通过调查问卷,分析了影响慢性病患者药品福利获得感的因素。文章指出,药品
          集中采购主要借助于医保统筹增加慢性病患者的药品福利,使得患者的福利获得感与实际所受药品福利存在偏差,进而针对公立
          医院、药企、医联体等分别提出了提高中选药品的覆盖范围、推进药品一致性评价、提供科学的药学指导服务等建议,为药品集中
          采购工作的进一步优化、提升患者获得感提供了政策建议。


          药品集中采购背景下慢性病患者药品福利获得感及影响因素                                                                    Δ


                         #
                *
          徐 赟 ,汤少梁(南京中医药大学卫生经济管理学院,南京 210046)
          中图分类号 R97;R19-0          文献标志码     A      文章编号     1001-0408(2022)19-2418-05
          DOI  10.6039/j.issn.1001-0408.2022.19.23

          摘   要 目的 研究药品集中采购背景下慢性病患者药品福利获得感及影响因素。方法 基于消费者剩余理论,对药品集中采购
          后慢性病患者药品福利获得感进行问卷调查与分析;建立有序Logit回归模型,探究慢性病患者药品福利获得感的影响因素。结
          果与结论 共发放问卷285份,回收285份,其中有效问卷215份(有效率为75.4%)。问卷调查结果显示,受慢性病门诊补贴及购药
          习惯等因素的影响,药品集中采购模式下慢性病患者药品福利获得感并略有提高,其药品福利获得感受年龄、受教育水平、月收
          入、医保类型影响显著(P<0.1或P<0.05)。分析可知相较于药品集中采购带来的药品价格降低,慢性病患者药品福利获得感稍
          有提升;药品集中采购主要是借助于医保统筹增加慢性病患者的药品福利。国家应加强对公立医院中选药品使用考核,推进药品
          一致性评价,提升患者对中选药品的信赖度,借助医联体、分级诊疗平台提供用药服务,进而增加慢性病患者的药品福利。
          关键词 药品福利;药品集中采购;慢性病患者;消费者剩余;有序Logit回归分析

          Sense of drug welfare acquisition and its influencing factors in patients with chronic diseases under the
          background of centralized drug purchasing
          XU Yun,TANG Shaoliang(School of Health Economics and Management,Nanjing University of Chinese
          Medicine,Nanjing 210046,China)

          ABSTRACT    OBJECTIVE To study the sense of drug welfare acquisition and its influencing factors in patients with chronic
          diseases under the background of centralized drug purchasing. METHODS Based on the theory of consumer surplus,questionnaire
          survey and analysis were performed about the sense of drug welfare acquisition in patients with chronic diseases under the
          background of centralized drug purchasing. The ordered Logit regression model was established to investigate the influencing factors
          for the sense of drug welfare acquisition. RESULTS & CONCLUSIONS A total of 285 questionnaires were distributed and 285
          were recovered,of which 215 were valid(the effective rate was 75.4%). The results of the questionnaire survey showed that,
          influenced by factors such as chronic disease outpatient subsidies and drug buying habits,the sense of drug welfare acquisition in
          chronic disease patients under the centralized drug purchasing mode had been significantly improved slightly,and the age,
          education level,monthly income and medical insurance type had significant impact on the sense of drug welfare acquisition(P<
          0.01 or P<0.05). Compared with the drop of drug price brought about by centralized drug purchasing,the sense of drug welfare
          acquisition in chronic disease patients has been improved slightly. The centralized drug purchasing is mainly to further increase the
          drug welfare for patients with chronic diseases with the help of medical insurance overall planning. Our country should strengthen
                                                              the assessment of selected drugs in public hospitals;promote
              Δ 基金项目 国 家 自 然 科 学 基 金 资 助 项 目(No. 72074125,No.  drug consistency evaluation to increase the trust of patients to
          71673148)
                                                              selected drugs;develop pharmaceutical services with the help
             *第一作者 硕士。研究方向:社会医学与卫生事业管理。E-
          mail:1565590163@qq.com                              of medical consortium and hierarchical diagnosis and treatment
              # 通信作者 教授,博士生导师,博士。研究方向:药物经济学。E-                platform to increase the drug welfare of patients with chronic
          mail:tangshaoliang@126.com                          diseases.


          ·2418·   China Pharmacy 2022 Vol. 33 No. 19                                 中国药房    2022年第33卷第19期
   119   120   121   122   123   124   125   126   127   128   129